Anebulo Pharmaceuticals, Inc. (ANEB) - Quarterly Balance Statement

Home
ANEB
Financials

1.15 (USD) • At close April 28, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	14.998	1.404	3.094	5.147	6.645	8.521	11.247	14.165	16.355	19.214	14.548	16.548	18.009	19.208	19.986	3.307	2.48	-3.025	3.025
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.05	0
Cash and Short Term Investments Numbers are in millions	14.998	1.404	3.094	5.147	6.645	8.521	11.247	14.165	16.355	19.214	14.548	16.548	18.009	19.208	19.986	3.307	2.48	3.025	3.025
Net Receivables Numbers are in millions	0.031	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.023	0	0	0.004
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	0.397	0.558	0.414	0.447	0.343	0.527	0.423	0.268	0.533	0.602	1.031	0.701	0.955	1.293	1.668	0.569	0.029	0	0
Total Current Assets Numbers are in millions	15.395	1.963	3.508	5.371	6.816	9.048	11.67	14.433	16.888	19.815	14.548	17.248	18.964	20.5	19.986	3.899	2.509	3.025	3.028
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.446	0.505	0.565	0.625	0.685	0	0.423	0	0	0	0	0	0	0	1.668	0.393	0.102	-3.025	0
Total Non-Current Assets Numbers are in millions	0.446	0.505	0.565	0.625	0.685	0	0.423	0	0	0	1.031	0	0	0	1.668	0.393	0.102	-3.025	0
Total Assets Numbers are in millions	15.841	2.468	4.073	5.996	7.501	9.048	11.67	14.433	16.888	19.815	15.579	17.248	18.964	20.5	21.653	4.291	2.611	0	3.028
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0.32	0.252	0.156	0.385	0.319	0.566	0.535	0.571	0.347	0.523	0.381	0.083	0.043	0.494	0.11	0.082	0.084	0	0
Short Term Debt Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.209	0	0.201
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities Numbers are in millions	0	0.317	0.104	0.625	0	0.151	0.534	0.92	1.026	0.175	0.132	0.003	0.007	0.114	0.132	0.211	0.06	0	0.023
Total Current Liabilities Numbers are in millions	0.32	0.569	0.261	1.01	1.014	0.717	1.069	1.491	1.372	0.698	0.513	0.086	0.05	0.608	0.242	0.293	0.354	0	0.224
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.559	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.434	2.976	0	0
Total Non-Current Liabilities Numbers are in millions	0.559	0	0	0.625	0.695	0.151	0.534	0	1.026	0	0.381	0.083	0.043	0.494	0.11	13.434	2.976	0	0
Total Liabilities Numbers are in millions	0.879	0.569	0.261	1.01	1.014	0.717	1.069	1.491	1.372	0.698	0.513	0.086	0.05	0.608	0.242	13.727	3.33	0	0.224
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.653	2,975.752	2.976	2.976	2.976
Common Stock Numbers are in millions	0.041	0.026	0.026	0.026	0.026	0.026	0.026	0.026	0.026	0.026	0.023	0.023	0.023	0.023	0.023	0.013	0.013	0	0.012
Retained Earnings Numbers are in millions	-70.068	-67.604	-65.404	-64.054	-62.4	-59.683	-57.202	-54.706	-51.908	-48.082	-45.47	-43.147	-41.27	-40.197	-38.644	-9.532	-0.768	0	-0.183
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0	0	0	0	0	0	0	-0	-0	0	0	-0	0	0	-0	-2,975.752	-0	-0.171	0
Other Total Stockholders Equity Numbers are in millions	84.989	69.477	69.19	69.013	68.862	67.989	67.778	67.622	67.399	67.173	60.513	60.286	60.161	60.067	60.033	2,978.811	-2.929	0	0
Total Shareholders Equity Numbers are in millions	14.962	1.899	3.813	4.985	6.487	8.331	10.601	12.942	15.516	19.117	15.067	17.163	18.914	19.893	21.412	-9.436	-0.719	2.805	2.805
Total Equity Numbers are in millions	14.962	1.899	3.813	4.985	6.487	8.331	10.601	12.942	15.516	19.117	15.067	17.163	18.914	19.893	21.412	-9.436	-0.719	2.805	2.805
Total Liabilities & Shareholders Equity Numbers are in millions	15.841	2.468	4.073	5.996	7.501	9.048	11.67	14.433	16.888	19.815	15.579	17.248	18.964	20.5	21.653	4.291	2.611	2.805	3.028

Anebulo Pharmaceuticals, Inc.

NASDAQ:ANEB Add to watchlist

NASDAQ:ANEB